Clinical trial
Isolating Mechanisms in the Treatment of Borderline Personality Disorder
NCT03408860 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Isolating Mechanisms in the Treatment of Borderline Personality Disorder
- Lead sponsor
- Boston University Charles River Campus
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 15, 2017
- Completion date
- August 30, 2020
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.